Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Net Debt Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual net debt in 2021 was 15.85 Million USD , down -86.99% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly net debt in 2022 Q2 was 21.33 Million USD , down -27.31% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported annual net debt of 121.84 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported quarterly net debt of 29.34 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported quarterly net debt of 15.85 Million USD for 2021 FY, down -86.99% from previous quarter.

Annual Net Debt Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Created with Highcharts 11.1.0YearsNet Debt20202020.12020.22020.32020.42020.52020.62020.72020.82020.920210 USD25000000 USD50000000 USD75000000 USD100000000 USD125000000 USD150000000 USD

Historical Annual Net Debt of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Net Debt Net Debt Growth
2021 15.85 Million USD -86.99%
2020 121.84 Million USD 0.0%

Peer Net Debt Comparison of Clarus Therapeutics Holdings, Inc.

Name Net Debt Net Debt Difference
AstraZeneca PLC 22.74 Billion USD 99.93%
Bristol-Myers Squibb Company PFD CONV 2 30 Billion USD 99.947%
CSPC Pharmaceutical Group Limited -1.59 Billion USD 100.995%
Novartis AG 12.95 Billion USD 99.878%
PT Kalbe Farma Tbk. -169.7 Million USD 109.342%